SR: President Trump strikes serious tone in succinct COVID briefing from the White House ((specialreportbaier)) ((lubuntu at wor2))

Reaction and analysis from the ‘Special Report’ All-Stars: National Public Radio’s Mara Liasson; TownHall.com’s Guy Benson and the Wall Street Journal’s Kim Strassel

SR: Postal woes raise concerns for presidential election ((specialreportbaier)) ((lubuntu at wor2))

A presidential election in the middle of a pandemic could make mail-in voting more popular than ever and prove to be a stress test for a U.S. Postal Service that’s drowning in debt; Fox Business correspondent Hillary Vaughn reports

SR: Republicans attack Liz Cheney over Fauci support ((specialreportbaier)) ((lubuntu at wor2))

Conservatives from the House Freedom Caucus accused Cheney of being too deferential to Dr. Anthony Fauci and questioning the president’s decisions to withdraw troops from Afghanistan and Germany; congressional correspondent Chad Pergram reports

SR: Joe Biden unveils $775 billion plan for caregivers ((specialreportbaier)) ((lubuntu at wor2))

The new policies that presumptive Democratic presidential nominee Joe Biden has rolled out in the last few weeks would cost north of $8 trillion, according to calculations done by FoxNews.com; Peter Doocy reports

SR: Pharmaceutical executives update congressional lawmakers on COVID vaccine development ((specialreportbaier)) ((lubuntu at wor2))

U.S. health officials remain optimistic a coronavirus vaccine could be ready by later this year or early 2021; Casey Stegall reports from Dallas

SR: Joe Biden urges supporters to begin planning how they will safely vote in November amid COVID pandemic ((specialreportbaier)) ((lubuntu at wor2))

Former Vice President Joe Biden has an 8-point lead over Trump nationally in a Fox News poll, but trails the president with voters who are extremely like to vote; Peter Doocy reports

SR: Promising COVID vaccine candidates enter next stage of trials ((specialreportbaier)) ((lubuntu at wor2))

An Oxford University team working with pharmaceutical company Astra Zeneca announced their vaccine candidate produces long-sought ‘double protection’; Doug McKelway reports from Washington

Design a site like this with WordPress.com
Get started